ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BELL Belluscura Plc

10.00
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Belluscura Plc LSE:BELL London Ordinary Share GB00BD3B8Z11 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.00 9.00 11.00 10.00 10.00 10.00 65,000 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 825k -18.52M -0.1100 -0.91 16.84M
Belluscura Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker BELL. The last closing price for Belluscura was 10p. Over the last year, Belluscura shares have traded in a share price range of 7.25p to 26.00p.

Belluscura currently has 168,408,232 shares in issue. The market capitalisation of Belluscura is £16.84 million. Belluscura has a price to earnings ratio (PE ratio) of -0.91.

Belluscura Share Discussion Threads

Showing 776 to 798 of 825 messages
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older
DateSubjectAuthorDiscuss
27/8/2024
07:48
Increasing MoM sales at BELL. All the commentary & analysis here.
brummy_git
27/8/2024
07:34
I used to hold Bell but so many delivery of product and subsequent quality failures. Hopefully they have turned the corner at last. Assuming Gross margins of 70% means they will not hit their forecast so I am assuming they are planning to cut costs significantly or will get better than 70%?
chester9
27/8/2024
07:14
I’d also question how much of their current orders are just distributor stocking. But having said that, it does seem they have finally found some traction.
dr biotech
27/8/2024
06:44
In Jan they said

“the Company expects to achieve positive Adjusted EBITDA from Q3 of 2024 onwards. Consequently, Revenue and Adjusted EBITDA for 2024 are expected to be lower than market expectations* at $16 to $19 million and $(0.75) to $(1.5) million, respectively”

Now
The Board anticipates that revenue for FY24 will be approximately $8 to $10 million depending on timing of the full commercial launch of the DISCOV-R. and that the Company will be EBITDA positive for Q1 FY25.
The Company expects annualised run rate revenue of $14 million to $16 million by the end of year.

dr biotech
19/7/2024
16:18
Setting them at £1 would have been better than 20p
weaverbeever
27/6/2024
08:13
Did you read the same RNS as me ?
aconceptisabrick
27/6/2024
07:50
Things definitely seem to be improving at Belluscura.

All the details & commentary here wrt today's Dec FY23 results.

brummy_git
25/6/2024
06:50
More confetti shares

BELL was always doomed when the ‘expert’ investor buywell started pumping it

danmart2
24/6/2024
09:07
I don't know why you would buy shares at 15p when the circular for the convertible loan note implies that the shares under that might be issued at just 9p:



£2.7m raised / 30,000,000 shares = 9p

JakNife

jaknife
24/6/2024
08:49
An opinion which is received with the value in which it was given, free of charge.
1chrism
24/6/2024
07:04
Positive investor support for Belluscura

All the details & commentary here.

brummy_git
24/6/2024
06:47
More shares issued for 300k. This business isn't performing as investors were led to believe.

Avoid in my opinion.

owenski
13/6/2024
12:30
eviltwin1 17 May '24 - 16:03 - 635 of 641 0 0 0
"classic case of amatuerish British business failing to commercialise its innovations. Why are we so inept as a country in building companies?"

1chrism 17 May '24 - 17:06 - 636 of 641 0 3 0
"We can be thankful that they are not as inept as some of the patrons of ADVFN. Belluscura are based in the US."


There is some similarity here with Polarean Imaging (POLX): which is another US lung health company that floated on AIM, but which has also disappointed greatly after an earlier large share price rise.

In contrast, Newmark Security (NWT) is a British technology company that has expanded very successfully into America.

From the bar graph on page 12 of NWT's annual report & accounts for the year ended 30.4.22:-
"Five years of consecutive revenue growth:
HCM in North America: £m"
2017: £0.9M.
2018: £1.2M.
2019: £4.0M.
2020: £5.9M.
2021: £6.5M.
2022: £8.7M.




Belluscura (BELL):-




Polarean Imaging (POLX):-

hedgehog 100
12/6/2024
10:20
This statement doesn't exactly give a lot of confidence - why not state overall sales rather than just US (or China). Not sure who would take up the loan notes either. Big chance of 100% loss for 7% pa.
dr biotech
12/6/2024
07:28
No surprises here, Paul Hill said he was doing a catch up interview with management some time ago and that never happened.

Bargepole. Avoid.

owenski
12/6/2024
06:26
Not good. No details of the CLN just that it's coming. Hmmm.
babbler
12/6/2024
06:24
All the details & commentary wrt today's trading update & proposed £2.4m placing of convertible loan notes.
brummy_git
17/5/2024
16:06
We can be thankful that they are not as inept as some of the patrons of ADVFN. Belluscura are based in the US.
1chrism
17/5/2024
15:03
classic case of amatuerish British business failing to commercialise its innovations. Why are we so inept as a country in building companies?
eviltwin1
17/5/2024
11:47
primed for 20p - 27p not much stock available keeps being nt trade could possibly see zak mir all over this on monday
yusuf77
16/5/2024
12:22
631 " Currently nothing available to buy online. "

Ah, another of those 'brummy git' stocks. That could be rather fortunate then.

glavey
16/5/2024
08:39
Someone(s) accumulating?
cottoner
16/5/2024
07:54
Similar pattern so far this morning.
Currently nothing available to buy online.

cottoner
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older